戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 tion and 10 (22%) with continuous venovenous hemofiltration.
2 irst patient received continuous veno-venous hemofiltration.
3 %FO) in the intensive care unit (ICU) before hemofiltration.
4 ately transitioned to continuous veno-venous hemofiltration.
5  and kidney transplantation and responded to hemofiltration.
6 a modified Liver Assist device incorporating hemofiltration.
7  Two patients required continuous venovenous hemofiltration, 1 of whom died and 1 of whom survived.
8 and circuit-associated in patients requiring hemofiltration and extracorporeal membrane oxygenation.
9 branes used in convective therapies, such as hemofiltration and hemodiafiltration.
10 ors can be removed from the circulation with hemofiltration and that adsorption plays an important ro
11 upport, vasopressors, continuous veno-venous hemofiltration, and blood product transfusions.
12 anically ventilated, nine were on continuous hemofiltration, and five required vasopressors.
13 ation cardiac arrest, continuous veno-venous hemofiltration, and hyperbilirubinemia during extracorpo
14  transport on ECLS, minimal anticoagulation, hemofiltration, and optimal systemic oxygen delivery.
15 luid removal by nontraditional peritoneal or hemofiltration approaches.
16 cial kidney (BAK) consists of a conventional hemofiltration cartridge in series with a renal tubule a
17 tificial kidney consisting of a conventional hemofiltration cartridge in series with a renal tubule a
18  The use of a modified continuous venovenous hemofiltration circuit for rewarming in a juvenile goat
19 imals were placed in a continuous venovenous hemofiltration circuit with either a sham RAD without ce
20  oxygenator (0.65 m) was inserted within the hemofiltration circuit, either upstream (n = 7) or downs
21 echnique of a modified continuous venovenous hemofiltration circuit.
22 armed using a modified continuous venovenous hemofiltration circuit.
23 s were connected to a continuous veno-venous hemofiltration (CVVH) (filtration: 80 ml/kg/h) or sham c
24 s is not equivalent on continuous venovenous hemofiltration (CVVH) compared with continuous venovenou
25                        Continuous venovenous hemofiltration (CVVH) is used for renal replacement and
26  F-80 dialyzers during continuous venovenous hemofiltration (CVVH) or continuous venovenous hemodialy
27                        Continuous venovenous hemofiltration (CVVH) represents a potential source of c
28 HA330 with high-volume continuous venovenous hemofiltration (CVVH), HA330, and standard-volume CVVH w
29 nstrates that the combination of a synthetic hemofiltration device and a renal tubule cell therapy de
30                      High-volume, continuous hemofiltration during CPB attenuates systemic edema form
31 mmediately placed in a continuous venovenous hemofiltration extracorporeal circuit with either a sham
32 n failure and required continuous venovenous hemofiltration for 16 days.
33 amine have shown that it is ineffective, and hemofiltration has become increasingly popular as a choi
34 al substitution therapy with hemodialysis or hemofiltration has been the only successful long-term ex
35                                              Hemofiltration (HF) could potentially remove inflammator
36                                  High volume hemofiltration (HVHF) (200 ml/kg/h) improves hemodynamic
37 d correcting metabolic acidosis, high-volume hemofiltration (HVHF) might halt the vicious circle lead
38 nstrate that the addition of cell therapy to hemofiltration in an acutely uremic animal model with se
39 poreal CO2 removal and continuous venovenous hemofiltration in patients with acute respiratory distre
40                                   Continuous hemofiltration may be used in patients with fulminant he
41 of patients receiving continuous veno-venous hemofiltration or continuous venovenous hemofiltration w
42 e undergone aggressive continuous venovenous hemofiltration or hemodiafiltration at Brooke Army Medic
43 on (2C); equivalency of continuous veno-veno hemofiltration or intermittent hemodialysis (2B); prophy
44  (1A); equivalency of continuous veno-venous hemofiltration or intermittent hemodialysis (2B); prophy
45 echanical fluid removal via ultrafiltration, hemofiltration, or hemodialysis may be needed for refrac
46 ne session of dialysis, continued venovenous hemofiltration, or peritoneal dialysis.
47 orty patients received continuous venovenous hemofiltration + RAD, and 18 received CRRT alone.
48 uids should be administered judiciously, and hemofiltration should be instituted early to remove flui
49                        Continuous venovenous hemofiltration therapy was titrated to maintain maximum
50 cal application of human progenitor cells in hemofiltration units, and additional studies may ultimat
51 taneously placed catheter and hepatic venous hemofiltration using a double balloon catheter positione
52 our throughout CPB, simultaneously replacing hemofiltration volume with a balanced salt solution (HF
53                     In 8 control animals, no hemofiltration was performed.
54 nous hemofiltration or continuous venovenous hemofiltration with a 0.9-m2 polyacrylonitrile filter at
55          The bioartificial kidney, combining hemofiltration with a device containing human tubular ce
56                We used continuous venovenous hemofiltration with dialysis following hepatectomy with
57 ncluding hemoperfusion, plasma exchange, and hemofiltration with hemoperfusion were associated with l